Cambridge, United States
Parabilis Medicines
undisclosed funding
IPO
Summary
Parabilis Medicines went public, marking the company’s IPO after years of development and prior financing support from GV. The company is described as advancing clinical-stage drug discovery for hard-to-target biology. Parabilis Medicines is a clinical-stage drug discovery company.